Social Media Influencers Fueling Parallel Market for Unlicensed Slimming Medication
An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
However, doctors and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.
Several experts said the popularity for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.
Platform Response and Content Elimination
According to TikTok, the service has taken down violative content and prohibited related hashtags and search suggestions. The organization stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at residence.
Within minutes of entering one community, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, health issues or previous experience.
Product Details and Costs
Within these communities, messages display black plastic parcels with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram stated it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously seen patients harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant medical dangers”.
